ELIZABETH SEARS-WILEY: Open Payments
NPI 1215394382 · SAN DIEGO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,435 in 37 payments from 8 companies in 2025. Trend: 2023 $1,378 · 2024 $2,045 · 2025 $1,435
Food & beverage: $1,334Education: $101
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 9 | $328 |
| Janssen Pharmaceuticals, Inc | 4 | $288 |
| Otsuka America Pharmaceutical, Inc. | 8 | $215 |
| Neurocrine BioSciences, Inc. | 3 | $209 |
| E.R. Squibb & Sons, L.L.C. | 6 | $171 |
| Teva Pharmaceuticals USA, Inc. | 5 | $168 |
| Vanda Pharmaceuticals Inc. | 1 | $40 |
| ABBVIE INC. | 1 | $16 |
Products named: INGREZZA, ARISTADA, COBENFY, INVEGA SUSTENNA, ABILIFY MAINTENA, LYBALVI, UZEDY, ABILIFY ASIMTUFII.
Industry payments across CA — which companies pay providers there.
